Ruth L. Esser

Koeln, NW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Combination of targeted pharmacotherapy and immunotherapy with anti-CD19 CAR NK cells in acute lymphoblastic leukemia.

Combination of targeted pharmacotherapy and immunotherapy with anti-CD19 CAR NK cells in acute lymphoblastic leukemia.

Journal: HemaSphere

Published: May 30, 2025

Automated manufacturing and characterization of clinical grade autologous CD20 CAR T cells for the treatment of patients with stage III/IV melanoma.

Automated manufacturing and characterization of clinical grade autologous CD20 CAR T cells for the treatment of patients with stage III/IV melanoma.

Journal: Frontiers in immunology

Published: October 26, 2023

Treatment of rheumatoid arthritis with baricitinib or upadacitinib is associated with reduced scaffold protein NEDD9 levels in CD4+ T cells.

Treatment of rheumatoid arthritis with baricitinib or upadacitinib is associated with reduced scaffold protein NEDD9 levels in CD4+ T cells.

Journal: Physiological reports

Published: May 18, 2023

Reduced humoral response to a third dose (booster) of SARS-CoV-2 mRNA vaccines by concomitant methotrexate therapy in elderly patients with rheumatoid arthritis.

Reduced humoral response to a third dose (booster) of SARS-CoV-2 mRNA vaccines by concomitant methotrexate therapy in elderly patients with rheumatoid arthritis.

Journal: RMD open

Published: September 25, 2022

Altered Immunomodulatory Responses in the CX3CL1/CX3CR1 Axis Mediated by hMSCs in an Early In Vitro SOD1G93A Model of ALS.

Altered Immunomodulatory Responses in the CX3CL1/CX3CR1 Axis Mediated by hMSCs in an Early In Vitro SOD1G93A Model of ALS.

Journal: Biomedicines

Published: August 31, 2022

High increase in levels of lipoprotein(a) in plasma of patients with rheumatoid arthritis after COVID-19.

High increase in levels of lipoprotein(a) in plasma of patients with rheumatoid arthritis after COVID-19.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: August 08, 2022

Truncated isoforms of GPSM2 containing the GoLoco motif region promote CD4+ T-cell migration in SLE.

Truncated isoforms of GPSM2 containing the GoLoco motif region promote CD4+ T-cell migration in SLE.

Journal: Lupus science & medicine

Published: June 02, 2022

Th1 and Th17 cells are resistant towards T cell activation-induced downregulation of CD6.

Th1 and Th17 cells are resistant towards T cell activation-induced downregulation of CD6.

Journal: Clinical immunology (Orlando, Fla.)

Published: March 24, 2022

GMP-Compliant Manufacturing of TRUCKs: CAR T Cells targeting GD2 and Releasing Inducible IL-18.

GMP-Compliant Manufacturing of TRUCKs: CAR T Cells targeting GD2 and Releasing Inducible IL-18.

Journal: Frontiers in immunology

Published: December 20, 2021

Kinase activity profiling reveals contribution of G-protein signaling modulator 2 deficiency to impaired regulatory T cell migration in rheumatoid arthritis.

Kinase activity profiling reveals contribution of G-protein signaling modulator 2 deficiency to impaired regulatory T cell migration in rheumatoid arthritis.

Journal: Journal of autoimmunity

Published: May 29, 2021

Induced dendritic cells co-expressing GM-CSF/IFN-α/tWT1 priming T and B cells and automated manufacturing to boost GvL.

Induced dendritic cells co-expressing GM-CSF/IFN-α/tWT1 priming T and B cells and automated manufacturing to boost GvL.

Journal: Molecular therapy. Methods & clinical development

Published: November 10, 2020

GMP-compatible manufacturing of three iPS cell lines from human peripheral blood.

GMP-compatible manufacturing of three iPS cell lines from human peripheral blood.

Journal: Stem cell research

Published: November 27, 2018

Showing 1-12 of 33

Last Updated: 09/26/2026